OPPapers.com Essay Index >> Business >> Merck
We have many free term papers and essays on Merck. We also have a wide variety of research papers and book reports available to you for free. You can browse our collection of term papers or use our search engine.
Merck Merck, being on one of the biggest pharmaceutical companies in the world today, came from a meek beginning and still encounters many problems today while trying
Merck & Co. Merck & Co. (MRK) $47.08 Closing price 4/16/04 EPS (FY end Dec.) EPS Growth Revenue 2003 Actual 2004 Est. 2005 Est. 2004 2005 2004 2005 1Q 0.68 0.72
Merck- Ethical background The company that I chose to research is Merck & Co., Inc. Merck is the leading research -driven pharmaceutical products and services company.
Merck Is Merck Inc. fully to blame for misleading the public about the safety of the pain medication Vioxx? This is the question that my research paper will examine
Merck Executive Summary In 2000, Merck & Co., Inc., a global research-driven pharmaceutical company, was facing a threat that patents of their most popular drugs
Submitted by helpme911 on September 28, 2005
Category: Business
Words: 2348 | Pages: 10
Views: 210
Popularity Rank: 68,996
Average Member Grade: N/A (Add a Comment / Grade this Paper)
Is Merck Inc. fully to blame for misleading the public about the safety of the pain medication Vioxx? This is the question that my research paper will examine by pulling the opinions of experts in the subject along with my own opinion. This issue impacts the company, the employees, owners, creditors, regulators, and communities. This is a very complex issue concerning the deaths of some, a company's very existence, along with millions of dollars.
On September 30, 2004 Merck & Co., Inc. announced that they would voluntary withdrawal Vioxx from the market worldwide. "Vioxx is a COX-2 selective non steroidal anti-inflammatory drug (NSAID). It is a prescription medication used to relieve signs and symptoms of arthritis and acute pain, which is only to be used by adult patients." (REF) The FDA did not require Merck to withdraw its product from the market however; it was an independent decision on Merck's part. (Hopkins) The FDA does share the same safety concerns for patients taking Vioxx and especially for those that take the drug regularly. After Merck pulled the drug off the market, the FDA issued a public health advisory concerning the use of Vioxx.
An argument can be made that this is indeed Merck's fault. Vioxx made it onto the market with a 17-15-majority vote. Even though Vioxx made its way to the market much controversy swirled around its introduction to the public. Ten of the thirty-two experts on the FDA COX-2 advisory panel that evaluated these drugs had what the Center for Science in Public Interest considered "affiliations" with the drug companies. (Adams) These experts that were considered "affiliates" did receive consulting fees, research support and speaker's fees.
Throughout my extensive research I was not able to find any information that linked any of these "experts" to Merck's more than anyone else. Why should this be a concern now? The only answer to that is because of lawsuits...
You must Login to view the entire paper.
If you are not a member yet, Sign Up for free!